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Background: PET-MR scanners are beginning to be employed for quantitative
myocardial perfusion imaging. In order to examine simultaneous perfusion
calculations, this work describes a feasibility study of simultaneous PET-MR of
gadolinium-based contrast agent (GBCA) and PET radiotracer in a novel cardiac
perfusion phantom.
Results: [18F]F− and GBCA were injected simultaneously into a cardiac phantom
using a range of ground-truth myocardial perfusion rates of 1 to 5 ml/g/min. PET
quantification of K1 (ml/g/min) was performed using a single tissue compartment
model. MR perfusion was calculated using a model-independent signal
deconvolution technique. PET and MR signal traces from the phantom aorta and
myocardial sections show true simultaneous PET and MR arterial input functions (AIF)
and myocardial uptake respectively at each perfusion rate. Calculation of perfusion
parameters showed both K1 and h(t = 0) (PET and MR perfusion parameters
respectively) to be linearly related with the ground truth perfusion rate (PT), and also
linearly related to each other (R2 = 0.99). The highest difference in perfusion values
between K1 and PT was 16% at 1 ml/g/min, and the mean difference for all other
perfusion rates was <3%.
Conclusions: The perfusion phantom allows accurate and reproducible simulation of
the myocardial kinetics for simultaneous PET-MR imaging, and may find use in
protocol design and development of PET-MR based quantification techniques and
direct comparison of quantification of the two modalities.
Keywords: PET-MR, Cardiology, Perfusion, FlowBackground
Cardiac magnetic resonance (CMR) plays an increasing role in the diagnosis and strati-
fication of patients with suspected coronary artery disease (CAD) justified by its high
spatial resolution, tissue contrast and the ability to provide reproducible quantitative
data on parameters such as left ventricular volumes and mass. CMR is also increas-
ingly used to assess inducible ischaemia (Fihn et al., 2012; Task Force et al., 2013). In
carefully controlled situations, CMR techniques have been shown to also provide
absolute quantitative measurements of myocardial blood flow (MBF) and myocardial
flow reserve (MFR) (Jerosch-Herold, 2010).© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made.
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accurate method for assessment of obstructive coronary artery disease (CAD), with a
sensitivity and specificity of approximately 90% (Di Carli et al., 2007) and is consid-
ered the reference method for non-invasive quantification of myocardial perfusion
(Bengel et al., 2009). Dynamic PET imaging can be performed using short-lived me-
tabolized tracers (e.g. [82Rb]Cl, [13N]NH3) or freely-diffusible tracers (e.g.
15O–H2O)
for quantification of absolute MBF and MFR.
The recent introduction of simultaneous hybrid PET-MR systems for combined mo-
lecular and functional imaging could be of great use in terms of understanding under-
lying cardiac pathophysiology and improving cross-modality validation. Multiple
images comprising structural and functional information of the same tissue in the
same physiological state can be acquired simultaneously. The combination of PET
and MR acquisitions can provide further benefits in cardiac imaging such as real-time
motion correction (Petibon et al., 2013), reduced patient scan time compared to
independent CMR and PET-CT scans (Ratib & Nkoulou, 2014), and a reduction in
exposure to ionizing radiation (Ratib et al., 2013).
Due to the demanding technical requirements of first-pass perfusion imaging, the use of
simultaneous PET-MR systems for quantitative cardiac imaging is only just emerging.
Sequential CMR and PET perfusion measurements in a on the same day have shown that
physiological variations in the time between studies (i.e. hemodynamic conditions) are a
major factor (Morton et al., 2012). Recent work has performed simultaneous PET-MR in
[18F]FDG cases to examine cardiac viability (Nensa & Schlosser, 2014), cardiac sarcoma
(Nensa et al., 2015) and active inflammation imaging of cardiac sarcoidosis (Schneider
et al., 2014). MFR determined from [15O]H20 PET from both PET-MR and PET-CT
systems has been compared from 10 patients, detailing a high intra-class correlation coef-
ficient of 0.98 (Kero et al., 2017). Another group studied the feasibility of acquiring MR
and PET perfusion profiles simultaneously using dynamic contrast enhancement MR
(DCE-MR) and [13N]NH3 PET for 10 patients, showing a correlation of R
2 = 0.67 for rest
and stress MBF and R2 = 0.48 for MFR (Zhang et al., 2013). A major confounding factor
in the correlation between PET and MR perfusion comparison involves the difference in
the tracer mechanism. Gadolinium based contrast agents (GBCA) do not undergo
any intracellular processes, remaining distributed only within the extracellular space,
whereas PET radiotracers typically enter and exit the myocyte. Thus there is also a
lack of similarities between approaches to quantify perfusion on CMR and PET tech-
niques such as modeling assumptions, fitting methods and parameter constraints
(Gerber, 2012). Also of note in simultaneous imaging is the potential effects of
contrast agent on the MR-based map for attenuation correction of PET sinograms
(Rischpler et al., 2013; Rischpler et al., 2015).
There is thus room to improve correlation between PET and CMR perfusion
quantification techniques, and a physiologically validated phantom with the capabil-
ity of simultaneous PET-MR acquisition is likely to add to the growing body of
knowledge. Our perfusion phantom has previously been validated to provide data
suitable for quantitative analysis (Zarinabad et al., 2012) and has been employed in
MR (Chiribiri et al., 2013) and CT quantification (Otton et al., 2013). Our work here
follows on from our first investigations of simultaneous PET-MR phantom acquisitions
using simultaneous injections of radiotracer and GBCA (O'Doherty et al., 2016). We
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techniques are related.Material and Methods
Phantom
We used an in-house designed and built myocardial perfusion phantom, which has
previously been described in detail (Chiribiri et al., 2013). Briefly, water is pumped
through an MR-safe myocardial perfusion phantom placed in the scanner. The
phantom is representative of the large thoracic vessels and of the heart of a 60 kg
subject. It is composed of four cardiac chambers (120 ml each) and associated
thoracic vessels (aorta, pulmonary artery, pulmonary vein, vena cava). A schematic
representation detailing the phantom itself and supporting precision pumping and
monitoring mechanisms is shown in Fig. 1. Myocardial perfusion is controlled in
real time by flow meters continuously sampling the flow rate by means of high-
precision digital flow meters (Atrato, Titan, Sherborne, United Kingdom) and pro-
viding re-adjustment of the speed of rotation of roller pumps through a feedback
mechanism. Perfusion values were obtained by means of measurements of the
distribution volume for the radioactive tracer and for the GBCA, and dividing the
flow rate by this value. All pump controls and flow/perfusion rates are handled remotely
from a custom-written LabVIEW application (LabVIEW Professional Development
System 2014, National Instruments, Austin TX, USA) running on dedicated workstation
and remotely controlled using an iPad application (Dashboard for LabVIEW, National
Instruments, Austin TX, USA). As no radiotracer or GBCA re-entered the system after
injection, we utilized a non-recirculating model in order to study first-pass myocardial
perfusion measurements.Fig. 1 Basic schematic representation of the phantom showing the control unit outside the scan room and
the phantom components inside the PET-MR scanner. VC = vena cava, PA/PV-pulmonary artery/vein, RA/
LA = right/left atrium, RV/LV-right/left ventricle. Image modified from Chiribiri et al. (Chiribiri et al., 2013)
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We performed PET-MR imaging on a 3 T Siemens Biograph mMR scanner (Siemens
Healthcare GmbH, Erlangen, Germany). The MR sequence consisted of a clinically
utilized imaging protocol, namely a 2D TurboFLASH saturation recovery gradient echo
sequence (TE = 1 ms, TR = 164 ms, Flip angle = 10o, slice thickness = 6 mm, pixel spa-
cing = 1.875 mm, matrix size 144 × 192 voxels, with temporal resolution of 1 image
per cardiac beat). MR data were acquired in a single transverse plane identified by
markings on the phantom, the locations of which correspond to a known dispersion
volume for the GBCA and radiotracer. Cardiac output flow rate was set to 3 l/min, with
true myocardial perfusion rates (hereon denoted PT) set to 1, 2, 3, 4 and 5 ml/g/min. A
previously validated dual-bolus protocol was used for GBCA injection, with a pre-bolus
of 0.001 mmol/kg of GBCA injected before a main bolus of 0.01 mmol/kg (Ishida et al.,
2011). A minimum pause of 30 s was allowed between the pre-bolus and the main
bolus of GBCA to ensure return of signal in the vascular and myocardial compartments
to baseline values.
3D PET data were acquired in a single list-mode file and re-binned into short frames
during the peak influx and washout phases (60 × 3 s) and longer frames towards the
end of the washout phase (12 × 15 s). PET image frames were reconstructed using the
standard manufacturer-issued filtered back-projection (FBP) algorithm available on the
scanner (344 × 344 matrix, Gaussian smoothing filter of 4 mm. Resulting PET voxel
sizes were 2.086 mm × 2.086 mm × 2.031 mm. Attenuation correction of PET data was
provided by the standard dual-point VIBE T1-weighted Dixon sequence available on
the mMR scanner front end (Martinez-Moller et al., 2009). Total attenuation of the
phantom is low as there is no attenuating material surrounding the phantom.
A mean injected activity of 207.8 ± 9 MBq was injected in order to exclude potential
confounding dead-time effects in the PET detectors which has been shown to occur in
clinical situations (O'Doherty et al., 2014; Renaud et al., 2016). After preloading of
[18F]F− into the tubing, the main bolus of GBCA (Gadovist®, Bayer HealthCare, Berlin,
Germany) and [18F]F− were injected simultaneously via a contrast injection system
(Spectris Solaris, Bayer AG, Leverkusen, Germany) through the vena cava tubing of the
phantom (Fig. 1). Simultaneous dynamic PET-MR imaging was performed for a total of
300 s. A single simultaneous PET-MR acquisition was performed at each PT step, and
each step was repeated for an estimate of repeatability of the phantom. After each scan,
water was pumped through the myocardial compartments of the phantom for a
minimum of 60 s between experiments to ensure a complete washout of GBCA and
radiotracer before the next scan.Image analysis
Dynamic PET images were analyzed in PMOD v 3.7 (PMOD Technologies, Zurich,
Switzerland) to produce time-activity curves (TACs). 2D MR images were analyzed in
OsiriX (OsiriX 64-bit, version 8.0.2, Pixmeo SARL, Geneva, Switzerland) to produce
time-intensity curves (TICs). A region of interest (ROI) of 1.6 cm (tubing diameter)
was placed over the aorta of the phantom, and ROIs of 4 cm diameter were placed over
the left and right myocardial sections, carefully including the complete section of the
vessel and tissue compartment in the segmentation. Positioning of ROIs on the PET
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dynamic 3D PET and 2D summed dynamic MR images using PMOD. ROIs were placed
on PET images over the same spatial extent as the MR ROIs. The PET volumes of
interest (VOIs) were 6.093 mm thick (3 PET slices) in the axial-dimension in order to
match the slice thickness of the MR data (6 mm). All PET data were decay-corrected
to the scan start time. We thus produced a set of TACs and TICs for the aorta and
myocardial compartments over the range of PT.
MR perfusion calculation
In-house software was used for perfusion quantification (Labview 2014 for Mac,
National Instruments, Austin, USA). A model-independent deconvolution approach
was used to calculate the tissue impulse response function, providing results in
units of 1/s (Patel et al., 2010) and was not scaled to be in units of ml/g/min.
Briefly, relative perfusion can be calculated based on the central volume principle
using a signal deconvolution method (Jerosch-Herold et al., 1998). The TIC for the
myocardial uptake function, M(t), can be calculated from the TIC for the arterial
input function, Cin(t), convolved with the tissue impulse response function h(t):
M tð Þ ¼
Z t
0
Cin t‐τð Þ⋅h tð Þdt ¼
Z t
0
Cin τð Þ‐Cout τð Þ½ dτ ð1Þ
in which Cout(t) denotes the contrast concentrations in the venous out-perfusion. We
performed this calculation using the pre-bolus curve, Cin(t), as an input function, in
order to minimize the effect of signal saturation by the main bolus of higher GBCA
concentration, an effect which has been noted in previous work in patients and with
this phantom at high GBCA dosages (Chiribiri et al., 2013; Ishida et al., 2011). In the
range of physiological concentration used in the pre-bolus injection, MR signal inten-
sity is proportional to GBCA concentration. The tissue impulse response function h(t)
has the shape of an exponential decay, and MR relative perfusion measurements were
calculated from the h(t)) when h(t = 0), i.e. at the peak value of the exponential decay.
The delay between the arterial input TIC and the myocardial TIC was accounted for in
the model (Zarinabad et al., 2013).
PET perfusion calculation
PET data was modeled using a one-tissue compartment model characterized by a one
blood compartment, one tissue compartment and two rate constants K1 (uptake rate
constant in units of ml/g/min) and k2 (clearance rate from tissue to blood constant in
units of min−1). For this phantom study, using [18F]F− we assume an extraction fraction
of 1.0 due to the lack of any metabolic processes, and thus the K1 constant is entirely
representative of perfusion. In order to eliminate any prospective bias, PET and MR
data were analyzed independently by two different authors blinded to the true myocardial
perfusion rates, PT (PET analysis by JOD, MR analysis by AC).
The terms ‘flow’ and ‘perfusion’ have been used interchangeably in both PET and MR
literature. Owing to the fact that rates of liquid through our phantom were calibrated
in terms of ml/g/min (i.e. units of perfusion) and K1 values from PET kinetic modeling
were in the same units, we opt to keep consistency with terminology and use the term
‘perfusion’ rather than ‘flow’ (i.e. units of ml/min).
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Simultaneous imaging
As the PET acquisition is fully 3D (25.8 cm field of view), all myocardial chambers can
be visualized simultaneously. Figure 2 illustrates the rapid passage of radiotracer from
the right atrium to ventricle, through the pulmonary circulation and into the left atrium
and ventricle and exiting through the aorta. Figure 3 displays a fused transaxial image
of the single MR slice with the corresponding merged 3 PET slices covering the same
axial extent. The expected GBCA and PET radiotracer distribution through the phan-
tom can be seen at increasing time points of the 2D MR imaging sequence and fused
PET-MR images detailing the first pass dynamics of the phantom. The inset image of
Fig. 3 shows the passage of MR contrast only, which temporally matches the distribution
of PET radiotracer.
Image processing of the ROI/VOIs to produce TACs and TICs allows comparison of
resulting mean PET kBq/ml to MR signal intensity during transit of the GBCA and radio-
tracer, as shown in Fig. 4. As the repeat injection of [18F]F− and GBCA was performed
using the same timings and methodology as the first test, the time traces produced by
both PET and MR data were similar. Although not shown in Fig. 4 for clarity, for a single
PT of 4 ml/g/min, one standard deviation of the mean PET activity concentration from
the VOI varied over time from ±2 to ±24%, while that of the MR mean ROI signal inten-
sity varied over time from ±13% to ±29%. Standard deviations were similar for other
values of PT. Figure 5 shows a comparison of the input functions from both imaging
methodologies normalised by their respective maximum signal intensities, firstly between
the main MR bolus peak of GBCA and the radiotracer (A), secondly between the MR pre-
bolus peak (which was used for the MR perfusion analysis) and a time-shifted PET TAC
overlaid to provide comparison (B), and finally a normalized comparison of the functions
obtained from the myocardial chamber (C). From these traces, it can be observed that the
input functions for both PET and MR models show similar characteristics.Fig. 2 Single coronal PET slice from the 3D phantom acquisition at a cardiac output rate of 3 L/min, showing
an example of radiotracer distribution in the myocardial chambers at increasing post-injection time points. All
images are shown at the same windowing and level. RA/LA = right/left atrium, RV/LV-right/left ventricle
Fig. 3 Example fused PET-MR images showing dynamics of GBCA and radiotracer transfer through the
phantom. a – bolus in the VC (t = 0 s). b – outperfusion from the RV through the PA (t = 3 s), c – coronary
circulation to the PV (t = 5 s) and the aorta (AO). Inset images show the time distribution of GBCA only
O’Doherty et al. European Journal of Hybrid Imaging  (2017) 1:4 Page 7 of 14Perfusion calculations
PET datasets were used to calculate perfusion (ml/g/min) via K1, and MR datasets to
calculate relative perfusion values via h(t = 0) as described above. Resulting K1 and
h(t = 0) and are shown in Table 1. Figure 6 shows three plots detailing the relationship
between K1 and PT, h(t = 0) and PT and also h(t = 0) and K1. The results show that K1
is linearly related to PT (R
2 = 0.99), and that h(t = 0) is also linearly related to both PT
and K1 (R
2 values of 0.99 in both cases).
Discussion
We performed PET-MR tests using a specialized cardiac phantom allowing assessment of
myocardial perfusion measurements with both imaging methodologies from simultaneously
acquired data. Both PET and MR are accurate tools for the assessment of myocardialFig. 4 Comparison of mean activity concentration (kBq/ml) time activity curves (TAC) and mean MR signal (AU)
time intensity curves (TIC) acquired from the phantom VOIs (PET-top) and ROIs (MR-bottom). Data are
presented for simultaneous PET and MR acquisitions for a myocardial perfusion rate, PT = 4 ml/g/min and
cardiac output of 3 L/min. Repeat scan data using ROI and VOI in the same positions are also plotted and show
a high level of repeatability. Error bars are omitted in order to improve visual clarity of overlapping traces
Fig. 5 Comparison of normalized (respective maximum signal intensity) AIFs derived from both PET and MR
signal traces at a myocardial perfusion rate of 4 ml/g/min and cardiac output of 3 l/min. Image (a) represents the
input functions from the main MR bolus and PET bolus, showing a longer washout of GBCA than radiotracer in
the main bolus. Image (b) details the MR prebolus with the same PET bolus as (a) but time-shifted to provide
comparison. Image (c) details the simultaneous curves from the myocardial compartment showing a clear
difference in transit time, potentially due to higher mass and viscosity of the GBCA
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of fully quantitative perfusion units remain a complex process due to the relationship
between signal intensity and gadolinium contrast and dependence on acquisition sequence
(Jerosch-Herold, 2010), Also 2D imaging is favoured due to dynamic imaging meaning that
perfusion calculations cannot be representative of the entire volume. In PET, the cost of the
perfusion exam can be prohibitive and the procedure is based on access to short-lived radio-
tracers thus requiring access to a cyclotron. There is also a not insignificant radiation dose
Table 1 Results of employing a one compartment kinetic model to the PET and deconvolution
model to the MR data (Eq. 1)
PET MR
PT K1
(ml/g/min)
K1
SE (%)
k2
(l/min)
k2
SE (%)
h(t = 0)
(s−1)
h(t = 0)
SE (%)(ml/g/min)
1 1.14 3.8 0.96 7.83 0.132 4.019
2 1.93 2 1.62 1.71 0.213 4.141
3 2.94 1.55 2.44 2.05 0.279 3.346
4 3.81 2.41 3.20 2.93 0.339 3.834
5 5.14 1.83 4.43 3.35 0.403 2.985
REPEAT
1 1.18 0.5 0.99 7.68 0.133 3.953
2 2.07 1.87 1.87 1.74 0.201 3.112
3 2.98 2.6 2.60 2.06 0.293 4.526
4 3.98 3.21 3.21 2.16 0.384 4.259
5 5.07 4.44 4.43 3.48 0.457 3.214
Fig. 6 Top - Resulting K1 values from a single compartment model for PET data plotted against PT. Middle –
MR values of h(t = 0) from model-independent deconvolution for MR images plotted against the range of
PT. Bottom - MR values of h(t = 0) plotted against the range of K1 from PET kinetic modeling
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formation generated by simultaneous late gadolinium enhancement and 18F–FDG
imaging (Rischpler et al., 2015). Although the principles of image formation between
MR and PET are based entirely on different physical principles, we have shown that
similar TACs and TICs from the arterial and myocardial compartments can be ob-
tained from a single short acquisition. Furthermore, it has been possible to show that
the results obtained with the employed MR and PET models are linearly related to
the true myocardial perfusion rate, PT.
The phantom is physiologically relevant and as such is able to explore some relevant
aspects of perfusion dynamics of the human heart. Figures 2 and 3 demonstrate the dis-
tribution of both GBCA and radiotracer through the right side of the cardiac chambers
followed by the left, with perfusion through the myocardial compartments following
shortly after. Simultaneous traces of PET activity concentration and MR signal intensity
in Fig. 4 demonstrate the transit of radiotracer and GBCA through the phantom, show-
ing that true simultaneity of PET and MR signals can be achieved in this phantom. Our
data also indicate that when a dual bolus approach is used in MR, linear perfusion
estimates to those obtained in PET can be achieved.
In this study, we adopted a dual-bolus injection scheme previously described and val-
idated by our group (Ishida et al., 2011; Schuster et al., 2013). The results of this study
demonstrate that this approach results in MR input functions which are very similar in
shape and transit time to the reference standard PET input functions (Fig. 5). The myo-
cardial compartment TAC and TIC closely match in terms of wash-in, however the MR
TIC can be observed to have a longer transit time than the radiotracer (Fig. 5, part C).
We propose that this may be due to the higher particle mass and viscosity of the GBCA
than the radiotracer.
One of the main benefits of the phantom model is its reproducibility. Figure 4
demonstrates that repeat acquisitions at the same PT give similar TAC and TIC. Upon
calculation of perfusion via PET (Table 1), K1 values when performed with independent
repeat acquisitions produce values in the range of 1.2% to 7.5% of each other. A similar
repeatability is shown in MR data with a repeatability of 0.6%–13% for h(t = 0). PET
measurements at PT = 1 ml/g/min showed an overestimation of PT by 16%, however
the PT rates of 2, 3, 4 and 5 ml/g/min were accurate to K1 values to within a maximum
of 2.65%, indicating good precision for repeated measurements and also a good accur-
acy to PT values above 1 ml/g/min. Inaccuracies in the true measurement of PT = 1 ml/
g/min due to physical accuracy of the roller pumps may account for the larger differ-
ences at this value of PT, and will be investigated in the next generation of the phantom
currently under development. Although h(t = 0) values represent relative perfusion
measurement and were not scaled to represent absolute perfusion units, their relation-
ship to PT and K1 can be clearly observed in Fig. 6, whereby a linear relationship was
found between h(t = 0) and K1, as well as h(t = 0) and PT. Another potential advantage
of the approach is the possibility to address differences in the way images are
acquired and modality-specific artifacts, such as saturation effects in MR or attenu-
ation correction in PET.
Total analysis time of each series of PET images was approximately 30 min, and MR
images were approximately 5–10 min. Owing to the geometrical differences between
phantom and patient images, semi-automated PET analysis software could not be used.
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transit of the radiotracer in water. In clinical image we expect a lower amount of data
and frames to analyse.
Attenuation correction is a major issue in clinical PET-MR imaging and the focus of
much research (Mehranian & Zaidi, 2015). In this work, we utilised GBCA for the
bolus injection, and in clinical studies the concentration used would be far higher.
Previous work by our group has shown that despite large concentrations of GBCA up
to 65 mM (presenting the scenario of GBCA bolus in the left ventricle simultaneously
with the PET radiotracer), the effect of attenuation of gamma photons by GBCA on
quantified activity concentration (kBq/ml) in the final reconstructed images is less than
5% when compared to no GBCA present (O'Doherty & Schleyer, 2017).
We believe that by providing a standardized setup and known perfusion rates, results,
claims and hypotheses from clinical studies can be further investigated. For example, in
a recent study by our group, MFR of 41 patients calculated from independent CMR
and PET scans have been shown to correlate well, however absolute CMR perfusion at
stress and rest correlated weakly and were positively biased compared to their PET
counterparts (Morton et al., 2012). This may indicate that errors in quantification have
a similar effect on stress and rest perfusion MBF values but are cancelled by calculation
of the MFR. Future experiments could verify this finding by the exclusion of physio-
logical variation. The phantom also allows comparison of kinetic models given the
known ground truth of perfusion rates, and the potential for development of new
hybrid kinetic models employing both PET and MR data.
Knowledge of the relationship between PT, K1 and h(t = 0) may allow the creation of
a modality-specific calibration curves. Particularly in the case of perfusion MR, this
could allow converting the results of the deconvolution operation from seconds−1 to
ml/g/min of perfusion. This approach could prove of value as a substitute for current
approaches based on constraining the deconvolution operation (Zarinabad et al., 2013;
Hautvast et al., 2012). This may lead to an improvement in the correlation between
absolute MBF values measured with MR and PET, which was shown to be suboptimal
in comparison with MPR values in previous studies (Morton et al., 2012).Limitations
The use of the phantom in this work for simultaneous PET-MR acquisitions as a surro-
gate for clinical acquisitions presents some fundamental limitations. Despite the fact that
the TIC and TAC curves are similar in appearance for this simplified phantom study, it
may not be the case for clinical studies in a human cohort due to the mechanism of trans-
port of radiotracer (intracellular) and GBCA (extracellular). Therefore the phantom study
serves to provide preliminary investigation into the standardized comparison between
PET and MR perfusion values in a controlled simulation. The phantom model used in our
experiments is not able to capture the broad range of body structures and physiological
states that may be present in a clinical setting and as such represents an oversimplification
of the cardiovascular system which cannot detail true myocardial diffusion or radiotracer
uptake. Furthermore, despite a good correlation between PET and MR perfusion, there
remain fundamental differences between the calculation methodology between the MR
model-independent deconvolution approach (leading to a parameter related to perfusion)
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with PET radiotracers, no separate tissue compartment exists, for example one with well-
defined mechanical properties such as a membrane. Therefore true intracellular uptake
cannot be simulated, only allowing non-circulating extravascular transfer of tracer. Strat-
egies would be required in order to simulate the kinetics of perfusion tracers that undergo
metabolic processes such as [13N]NH3 or [
18F]flurpiridaz. Efforts should be made to create
myocardial compartments within the phantom, which would allow a more accurate
approach to kinetic modeling. Furthermore, we performed only 1 repeat acquisition of
each PT in this feasibility study, further repeat measurements would allow the calculation
of a repeatability coefficient for both the PET and MR datasets.
The current phantom model setup is unable to reproduce the multiple sources of
image artifacts in PET-MR such as the effects of motion due to respiratory or cardiac
contraction. Thus the phantom allows an environment free from these potentially con-
founding effects focusing only on the assessment of the perfusion dynamics within the
cardiac compartments. However, translation of calibrations from the phantom to the
clinical setting should be treated with caution. Confounding factors from clinical data
may include the use of respiratory correction via importing an average cine CT or
using MR-based navigators (Ouyang et al., 2013) or employing MR motion-field based
cardiac motion correction employed in PET reconstruction (Huang et al., 2015). Efforts
to apply these techniques specifically to quantitative dynamic PET-MR cardiology are
in their infancy, although some techniques are currently under development for static
imaging (Nensa et al., 2013; Vontobel et al., 2015).Conclusion
We have performed a feasibility study of the first simultaneous PET-MR acquisitions from a
dynamic cardiac perfusion phantom, showing similar first-pass dynamics of both the PET
and MR contrast agents. We have described the resulting simultaneous traces, showed ini-
tial repeatability of the phantom studies and also demonstrated a correlation between perfu-
sion quantification of the PET time-activity traces using a kinetic model, relative MR
perfusion using a deconvolution model and the true manually set myocardial perfusion rate.
The phantom shows potential for improving standardisation of perfusion measurements,
analysis routines, development of imaging protocols and potential calibration of MR perfu-
sion values. We have also described the major limitations of the system, detailing how these
phantom studies are an important stepping stone allowing investigation of sequence devel-
opment/comparison and kinetic model development in both PETand MR modalities.
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